CHEBI ONTOLOGY - ANNOTATIONS
The Chemical Entities of Biological Interest (ChEBI) ontology is downloaded weekly from EMBL-EBI at http://www.ebi.ac.uk/chebi/ . The data is made available under the Creative Commons License (CC BY 3.0, http://creativecommons.org/licenses/by/3.0/ ). For more information see: Degtyarenko et al. (2008) ChEBI: a database and ontology for chemical entities of biological interest. Nucleic Acids Res. 36, D344–D350.
Term: methylmercury(1+)
Accession: CHEBI:49747
browse the term
Definition: A methylmercury compound that has formula CH3Hg.
Synonyms: related_synonym: CH3Hg+; Formula=CH3Hg; InChI=1S/CH3.Hg/h1H3;/q;+1; InChIKey=DBUXSCUEGJMZAE-UHFFFAOYSA-N; METHYL MERCURY ION; Methylmercury II; Methylmercury ion; SMILES=C[Hg+]; [HgCH3](+); [HgMe](+); methylmercury ion(1+); methylmercury(II) cation; monomethylmercury cation
alt_id: CHEBI:30784; CHEBI:49745
xref: Beilstein:3902999; CAS:22967-92-6; DrugBank:DB03674; Gmelin:1406; KEGG:C18672
xref_mesh: MESH:C030957
xref: PDBeChem:MMC
G
ABI3
ABI family member 3
decreases expression
EXP
methylmercury II results in decreased expression of ABI3 mRNA
CTD
PMID:26314263
NCBI chr17:49,210,707...49,223,225
Ensembl chr17:49,210,411...49,223,225
G
ACTN1
actinin alpha 1
increases expression
EXP
methylmercury II results in increased expression of ACTN1 mRNA
CTD
PMID:26314263
NCBI chr14:68,874,128...68,979,302
Ensembl chr14:68,874,128...68,979,440
G
ACVR1C
activin A receptor type 1C
multiple interactions
ISO
[Benzene co-treated with methylmercury II co-treated with Trichloroethylene] results in decreased expression of ACVR1C mRNA
CTD
PMID:17905399
NCBI chr 2:157,526,767...157,628,864
Ensembl chr 2:157,526,767...157,628,864
G
ADD1
adducin 1
increases expression
ISO
methylmercury II results in increased expression of ADD1 mRNA
CTD
PMID:17905399
NCBI chr 4:2,843,844...2,930,062
Ensembl chr 4:2,843,844...2,930,076
G
ALB
albumin
increases expression
ISO
methylmercury II results in increased expression of ALB mRNA
CTD
PMID:17905399
NCBI chr 4:73,404,287...73,421,482
Ensembl chr 4:73,397,114...73,421,482
G
AMN
amnion associated transmembrane protein
increases expression
ISO
methylmercury II results in increased expression of AMN mRNA
CTD
PMID:17905399
NCBI chr14:102,922,663...102,930,842
Ensembl chr14:102,922,663...102,933,596
G
ANG
angiogenin
decreases expression
EXP
methylmercury II results in decreased expression of ANG mRNA
CTD
PMID:26314263
NCBI chr14:20,684,177...20,694,186
Ensembl chr14:20,684,177...20,698,971
G
ANPEP
alanyl aminopeptidase, membrane
multiple interactions
ISO
[Benzene co-treated with methylmercury II co-treated with Trichloroethylene] results in decreased expression of ANPEP mRNA
CTD
PMID:17905399
NCBI chr15:89,784,895...89,814,852
Ensembl chr15:89,784,895...89,815,401
G
ARHGAP18
Rho GTPase activating protein 18
multiple interactions
ISO
[Benzene co-treated with methylmercury II co-treated with Trichloroethylene] results in increased expression of ARHGAP18 mRNA
CTD
PMID:17905399
NCBI chr 6:129,576,132...129,710,177
Ensembl chr 6:129,576,132...129,710,177
G
ASNS
asparagine synthetase (glutamine-hydrolyzing)
increases expression
ISO
methylmercury II results in increased expression of ASNS mRNA
CTD
PMID:17905399
NCBI chr 7:97,851,677...97,928,441
Ensembl chr 7:97,851,677...97,872,542
G
ATF5
activating transcription factor 5
multiple interactions
ISO
[Benzene co-treated with methylmercury II co-treated with Trichloroethylene] results in increased expression of ATF5 mRNA
CTD
PMID:17905399
NCBI chr19:49,928,906...49,933,935
Ensembl chr19:49,928,702...49,933,935
G
ATP5IF1
ATP synthase inhibitory factor subunit 1
increases expression
ISO
methylmercury II results in increased expression of ATP5IF1 mRNA
CTD
PMID:17905399
NCBI chr 1:28,236,124...28,238,100
Ensembl chr 1:28,236,109...28,246,906
G
BCL2L1
BCL2 like 1
multiple interactions
ISO
[Benzene co-treated with methylmercury II co-treated with Trichloroethylene] results in increased expression of BCL2L1 mRNA
CTD
PMID:17905399
NCBI chr20:31,664,452...31,723,963
Ensembl chr20:31,664,452...31,723,989
G
BET1
Bet1 golgi vesicular membrane trafficking protein
multiple interactions
ISO
[Benzene co-treated with methylmercury II co-treated with Trichloroethylene] results in increased expression of BET1 mRNA
CTD
PMID:17905399
NCBI chr 7:93,962,762...94,004,355
Ensembl chr 7:93,962,762...94,004,382
G
BNIP3
BCL2 interacting protein 3
multiple interactions
ISO
[Benzene co-treated with methylmercury II co-treated with Trichloroethylene] results in increased expression of BNIP3 mRNA
CTD
PMID:17905399
NCBI chr10:131,967,684...131,981,923
Ensembl chr10:131,967,684...131,981,967
G
CASP3
caspase 3
multiple interactions
ISO
[Benzene co-treated with methylmercury II co-treated with Trichloroethylene] results in increased expression of CASP3 mRNA
CTD
PMID:17905399
NCBI chr 4:184,627,696...184,649,447
Ensembl chr 4:184,627,696...184,650,062
G
CCNG1
cyclin G1
multiple interactions
ISO
[Benzene co-treated with methylmercury II co-treated with Trichloroethylene] results in increased expression of CCNG1 mRNA
CTD
PMID:17905399
NCBI chr 5:163,437,571...163,457,640
Ensembl chr 5:163,437,569...163,446,151
G
CD47
CD47 molecule
multiple interactions
ISO
[Benzene co-treated with methylmercury II co-treated with Trichloroethylene] results in increased expression of CD47 mRNA
CTD
PMID:17905399
NCBI chr 3:108,043,091...108,091,031
Ensembl chr 3:108,043,091...108,091,862
G
CD63
CD63 molecule
multiple interactions
ISO
[Benzene co-treated with methylmercury II co-treated with Trichloroethylene] results in decreased expression of CD63 mRNA
CTD
PMID:17905399
NCBI chr12:55,723,535...55,730,041
Ensembl chr12:55,725,323...55,729,707
G
CDK5R1
cyclin dependent kinase 5 regulatory subunit 1
decreases expression
EXP
methylmercury II results in decreased expression of CDK5R1 mRNA
CTD
PMID:26314263
NCBI chr17:32,486,993...32,491,253
Ensembl chr17:32,486,993...32,491,253
G
CDK6
cyclin dependent kinase 6
multiple interactions
ISO
[Benzene co-treated with methylmercury II co-treated with Trichloroethylene] results in increased expression of CDK6 mRNA
CTD
PMID:17905399
NCBI chr 7:92,604,921...92,836,573
Ensembl chr 7:92,604,921...92,836,573
G
CFL1
cofilin 1
multiple interactions
ISO
methylmercury II affects the localization of and results in decreased phosphorylation of CFL1 protein; Probucol inhibits the reaction [methylmercury II affects the localization of and results in decreased phosphorylation of CFL1 protein]
CTD
PMID:27241350
NCBI chr11:65,854,673...65,858,180
Ensembl chr11:65,823,022...65,862,026
G
CHP1
calcineurin like EF-hand protein 1
multiple interactions
ISO
[Benzene co-treated with methylmercury II co-treated with Trichloroethylene] results in increased expression of CHP1 mRNA
CTD
PMID:17905399
NCBI chr15:41,231,268...41,281,887
Ensembl chr15:41,230,839...41,281,887
G
CISH
cytokine inducible SH2 containing protein
increases expression
ISO
methylmercury II results in increased expression of CISH mRNA
CTD
PMID:17905399
NCBI chr 3:50,606,489...50,611,774
Ensembl chr 3:50,606,489...50,611,774
G
CITED2
Cbp/p300 interacting transactivator with Glu/Asp rich carboxy-terminal domain 2
multiple interactions
ISO
[Benzene co-treated with methylmercury II co-treated with Trichloroethylene] results in decreased expression of CITED2 mRNA
CTD
PMID:17905399
NCBI chr 6:139,371,807...139,374,648
Ensembl chr 6:139,371,807...139,374,648
G
CLDN14
claudin 14
decreases expression
EXP
methylmercury II results in decreased expression of CLDN14 mRNA
CTD
PMID:26314263
NCBI chr21:36,460,621...36,576,569
Ensembl chr21:36,460,621...36,576,569
G
CLIC4
chloride intracellular channel 4
increases expression
EXP
methylmercury II results in increased expression of CLIC4 mRNA
CTD
PMID:26314263
NCBI chr 1:24,745,447...24,844,321
Ensembl chr 1:24,745,382...24,844,321
G
COL1A1
collagen type I alpha 1 chain
multiple interactions
ISO
[Benzene co-treated with methylmercury II co-treated with Trichloroethylene] results in increased expression of COL1A1 mRNA
CTD
PMID:17905399
NCBI chr17:50,184,101...50,201,631
Ensembl chr17:50,184,101...50,201,632
G
COL3A1
collagen type III alpha 1 chain
multiple interactions
ISO
[Benzene co-treated with methylmercury II co-treated with Trichloroethylene] results in decreased expression of COL3A1 mRNA
CTD
PMID:17905399
NCBI chr 2:188,974,373...189,012,746
Ensembl chr 2:188,974,373...189,012,746
G
CSNK2A1
casein kinase 2 alpha 1
multiple interactions
ISO
[Benzene co-treated with methylmercury II co-treated with Trichloroethylene] results in increased expression of CSNK2A1 mRNA
CTD
PMID:17905399
NCBI chr20:472,498...543,790
Ensembl chr20:472,498...543,835
G
CTNNA1
catenin alpha 1
increases expression
EXP
methylmercury II results in increased expression of CTNNA1 mRNA
CTD
PMID:26314263
NCBI chr 5:138,753,425...138,935,034
Ensembl chr 5:138,610,967...138,935,034
G
CTNNB1
catenin beta 1
increases expression
EXP
methylmercury II results in increased expression of CTNNB1 mRNA
CTD
PMID:26314263
NCBI chr 3:41,199,505...41,240,443
Ensembl chr 3:41,194,741...41,260,096
G
CTTN
cortactin
increases expression multiple interactions
ISO
methylmercury II results in increased expression of CTTN mRNA Probucol inhibits the reaction [methylmercury II results in increased expression of CTTN mRNA]
CTD
PMID:27241350
NCBI chr11:70,398,529...70,436,575
Ensembl chr11:70,398,404...70,436,584
G
CXCL8
C-X-C motif chemokine ligand 8
affects expression
EXP
methylmercury II affects the expression of CXCL8 mRNA
CTD
PMID:26314263
NCBI chr 4:73,740,569...73,743,716
Ensembl chr 4:73,740,519...73,743,716
G
CXCR4
C-X-C motif chemokine receptor 4
increases expression
EXP
methylmercury II results in increased expression of CXCR4 mRNA
CTD
PMID:26314263
NCBI chr 2:136,114,349...136,118,149
Ensembl chr 2:136,114,349...136,119,177
G
DAP
death associated protein
increases expression
ISO
methylmercury II results in increased expression of DAP mRNA
CTD
PMID:17905399
NCBI chr 5:10,679,230...10,761,234
Ensembl chr 5:10,679,230...10,761,234
G
DHCR24
24-dehydrocholesterol reductase
multiple interactions
ISO
[Benzene co-treated with methylmercury II co-treated with Trichloroethylene] results in decreased expression of DHCR24 mRNA
CTD
PMID:17905399
NCBI chr 1:54,849,627...54,887,195
Ensembl chr 1:54,849,627...54,887,195
G
DUSP1
dual specificity phosphatase 1
increases expression
ISO
methylmercury II results in increased expression of DUSP1 mRNA
CTD
PMID:17905399
NCBI chr 5:172,768,096...172,771,195
Ensembl chr 5:172,768,096...172,771,195
G
DUSP6
dual specificity phosphatase 6
increases expression
ISO
methylmercury II results in increased expression of DUSP6 mRNA
CTD
PMID:17905399
NCBI chr12:89,347,235...89,352,501
Ensembl chr12:89,347,235...89,352,501
G
ECE1
endothelin converting enzyme 1
multiple interactions
ISO
[Benzene co-treated with methylmercury II co-treated with Trichloroethylene] results in decreased expression of ECE1 mRNA
CTD
PMID:17905399
NCBI chr 1:21,217,250...21,345,504
Ensembl chr 1:21,217,247...21,345,572
G
EGR1
early growth response 1
multiple interactions
ISO
[Benzene co-treated with methylmercury II co-treated with Trichloroethylene] results in decreased expression of EGR1 mRNA
CTD
PMID:17905399
NCBI chr 5:138,465,479...138,469,303
Ensembl chr 5:138,465,479...138,469,303
G
FBXO3
F-box protein 3
multiple interactions
ISO
[Benzene co-treated with methylmercury II co-treated with Trichloroethylene] results in increased expression of FBXO3 mRNA
CTD
PMID:17905399
NCBI chr11:33,740,944...33,774,520
Ensembl chr11:33,740,939...33,774,543
G
GADD45A
growth arrest and DNA damage inducible alpha
increases expression
ISO
methylmercury II results in increased expression of GADD45A mRNA
CTD
PMID:17905399
NCBI chr 1:67,685,201...67,688,334
Ensembl chr 1:67,685,201...67,688,334
G
GADD45G
growth arrest and DNA damage inducible gamma
increases expression
ISO
methylmercury II results in increased expression of GADD45G mRNA
CTD
PMID:17905399
NCBI chr 9:89,605,012...89,606,555
Ensembl chr 9:89,605,012...89,606,555
G
GC
GC vitamin D binding protein
decreases expression
ISO
methylmercury II results in decreased expression of GC mRNA
CTD
PMID:17905399
NCBI chr 4:71,741,693...71,805,520
Ensembl chr 4:71,741,696...71,804,041
G
GPX1
glutathione peroxidase 1
multiple interactions decreases expression
ISO
Probucol promotes the reaction [methylmercury II results in decreased expression of GPX1 mRNA]
CTD
PMID:27241350
NCBI chr 3:49,357,176...49,358,353
Ensembl chr 3:49,357,174...49,358,605
G
GUCA2B
guanylate cyclase activator 2B
increases expression
ISO
methylmercury II results in increased expression of GUCA2B mRNA
CTD
PMID:17905399
NCBI chr 1:42,153,410...42,155,820
Ensembl chr 1:42,153,410...42,155,820
G
HHEX
hematopoietically expressed homeobox
increases expression
ISO
methylmercury II results in increased expression of HHEX mRNA
CTD
PMID:17905399
NCBI chr10:92,689,955...92,695,647
Ensembl chr10:92,689,955...92,695,647
G
HPGD
15-hydroxyprostaglandin dehydrogenase
decreases expression
ISO
methylmercury II results in decreased expression of HPGD mRNA
CTD
PMID:17905399
NCBI chr 4:174,490,175...174,522,893
Ensembl chr 4:174,490,175...174,523,154
G
HTATIP2
HIV-1 Tat interactive protein 2
increases expression
ISO
methylmercury II results in increased expression of HTATIP2 mRNA
CTD
PMID:17905399
NCBI chr11:20,363,714...20,383,782
Ensembl chr11:20,363,685...20,383,782
G
ID2
inhibitor of DNA binding 2
multiple interactions
ISO
[Benzene co-treated with methylmercury II co-treated with Trichloroethylene] results in increased expression of ID2 mRNA
CTD
PMID:17905399
NCBI chr 2:8,682,056...8,684,461
Ensembl chr 2:8,678,845...8,684,461
G
IGFBP1
insulin like growth factor binding protein 1
decreases expression
ISO
methylmercury II results in decreased expression of IGFBP1 mRNA
CTD
PMID:17905399
NCBI chr 7:45,888,488...45,893,660
Ensembl chr 7:45,888,360...45,893,660
G
IGFBP3
insulin like growth factor binding protein 3
multiple interactions
ISO
[Benzene co-treated with methylmercury II co-treated with Trichloroethylene] results in decreased expression of IGFBP3 mRNA
CTD
PMID:17905399
NCBI chr 7:45,912,245...45,921,272
Ensembl chr 7:45,912,245...45,921,874
G
IL13RA1
interleukin 13 receptor subunit alpha 1
multiple interactions
ISO
[Benzene co-treated with methylmercury II co-treated with Trichloroethylene] results in increased expression of IL13RA1 mRNA
CTD
PMID:17905399
NCBI chr X:118,727,606...118,805,228
Ensembl chr X:118,727,133...118,794,535
G
ITGA4
integrin subunit alpha 4
increases expression
EXP
methylmercury II results in increased expression of ITGA4 mRNA
CTD
PMID:26314263
NCBI chr 2:181,457,205...181,538,940
Ensembl chr 2:181,457,202...181,538,940
G
ITGAL
integrin subunit alpha L
increases expression
EXP
methylmercury II results in increased expression of ITGAL mRNA
CTD
PMID:26314263
NCBI chr16:30,472,742...30,523,185
Ensembl chr16:30,472,658...30,523,567
G
ITGB2
integrin subunit beta 2
increases expression
EXP
methylmercury II results in increased expression of ITGB2 mRNA
CTD
PMID:26314263
NCBI chr21:44,885,953...44,928,815
Ensembl chr21:44,885,953...44,931,989
G
JAM3
junctional adhesion molecule 3
increases expression
EXP
methylmercury II results in increased expression of JAM3 mRNA
CTD
PMID:26314263
NCBI chr11:134,069,072...134,152,001
Ensembl chr11:134,069,071...134,152,001
G
LAMB1
laminin subunit beta 1
decreases expression
EXP
methylmercury II results in decreased expression of LAMB1 mRNA
CTD
PMID:26314263
NCBI chr 7:107,923,799...108,003,161
Ensembl chr 7:107,923,799...108,003,213
G
LIMK1
LIM domain kinase 1
multiple interactions increases expression
ISO
Probucol inhibits the reaction [methylmercury II results in increased expression of LIMK1 mRNA]
CTD
PMID:27241350
NCBI chr 7:74,083,804...74,122,525
Ensembl chr 7:74,082,933...74,122,525
G
LTBR
lymphotoxin beta receptor
multiple interactions
ISO
[Benzene co-treated with methylmercury II co-treated with Trichloroethylene] results in decreased expression of LTBR mRNA
CTD
PMID:17905399
NCBI chr12:6,375,160...6,391,566
Ensembl chr12:6,375,045...6,391,571
G
MAPK12
mitogen-activated protein kinase 12
decreases expression
EXP
methylmercury II results in decreased expression of MAPK12 mRNA
CTD
PMID:26314263
NCBI chr22:50,252,901...50,261,683
Ensembl chr22:50,245,450...50,261,716
G
MAPK14
mitogen-activated protein kinase 14
increases expression
EXP
methylmercury II results in increased expression of MAPK14 mRNA
CTD
PMID:26314263
NCBI chr 6:36,027,808...36,124,214
Ensembl chr 6:36,027,782...36,111,236
G
MAPKAPK2
MAPK activated protein kinase 2
multiple interactions
ISO
[Benzene co-treated with methylmercury II co-treated with Trichloroethylene] results in decreased expression of MAPKAPK2 mRNA
CTD
PMID:17905399
NCBI chr 1:206,684,905...206,734,281
Ensembl chr 1:206,684,905...206,734,281
G
MCL1
MCL1 apoptosis regulator, BCL2 family member
increases expression
ISO
methylmercury II results in increased expression of MCL1 mRNA
CTD
PMID:17905399
NCBI chr 1:150,574,558...150,579,610
Ensembl chr 1:150,560,895...150,579,738
G
MDM2
MDM2 proto-oncogene
multiple interactions
ISO
[Benzene co-treated with methylmercury II co-treated with Trichloroethylene] results in increased expression of MDM2 mRNA
CTD
PMID:17905399
NCBI chr12:68,808,172...68,850,686
Ensembl chr12:68,808,177...68,845,544
G
MFGE8
milk fat globule EGF and factor V/VIII domain containing
multiple interactions
ISO
[Benzene co-treated with methylmercury II co-treated with Trichloroethylene] results in decreased expression of MFGE8 mRNA
CTD
PMID:17905399
NCBI chr15:88,898,683...88,913,379
Ensembl chr15:88,898,683...88,913,468
G
MTPN
myotrophin
multiple interactions
ISO
[Benzene co-treated with methylmercury II co-treated with Trichloroethylene] results in increased expression of MTPN mRNA
CTD
PMID:17905399
NCBI chr 7:135,926,760...135,977,359
Ensembl chr 7:135,926,760...135,977,359
G
MYL5
myosin light chain 5
affects expression
EXP
methylmercury II affects the expression of MYL5 mRNA
CTD
PMID:26314263
NCBI chr 4:674,542...682,028
Ensembl chr 4:673,580...682,028
G
NDUFS1
NADH:ubiquinone oxidoreductase core subunit S1
multiple interactions
ISO
[Benzene co-treated with methylmercury II co-treated with Trichloroethylene] results in increased expression of NDUFS1 mRNA
CTD
PMID:17905399
NCBI chr 2:206,114,817...206,159,444
Ensembl chr 2:206,114,817...206,159,509
G
NF1
neurofibromin 1
increases expression
EXP
methylmercury II results in increased expression of NF1 mRNA
CTD
PMID:26314263
NCBI chr17:31,094,927...31,377,677
Ensembl chr17:31,094,927...31,382,116
G
NFKB1
nuclear factor kappa B subunit 1
multiple interactions
ISO
[Benzene co-treated with methylmercury II co-treated with Trichloroethylene] results in decreased expression of NFKB1 mRNA
CTD
PMID:17905399
NCBI chr 4:102,501,359...102,617,302
Ensembl chr 4:102,501,330...102,617,302
G
NHERF1
NHERF family PDZ scaffold protein 1
multiple interactions
ISO
[Benzene co-treated with methylmercury II co-treated with Trichloroethylene] results in decreased expression of NHERF1 mRNA
CTD
PMID:17905399
NCBI chr17:74,748,628...74,769,353
Ensembl chr17:74,748,628...74,769,353
G
NR0B2
nuclear receptor subfamily 0 group B member 2
decreases expression
ISO
methylmercury II results in decreased expression of NR0B2 mRNA
CTD
PMID:17905399
NCBI chr 1:26,911,489...26,913,975
Ensembl chr 1:26,911,489...26,913,975
G
NR2F6
nuclear receptor subfamily 2 group F member 6
multiple interactions
ISO
[Benzene co-treated with methylmercury II co-treated with Trichloroethylene] results in decreased expression of NR2F6 mRNA
CTD
PMID:17905399
NCBI chr19:17,231,883...17,245,919
Ensembl chr19:17,231,883...17,245,919
G
ONECUT1
one cut homeobox 1
increases expression
ISO
methylmercury II results in increased expression of ONECUT1 mRNA
CTD
PMID:17905399
NCBI chr15:52,755,053...52,790,336
Ensembl chr15:52,755,053...52,791,078
G
P2RY2
purinergic receptor P2Y2
decreases expression
ISO
methylmercury II results in decreased expression of P2RY2 mRNA
CTD
PMID:17905399
NCBI chr11:73,218,281...73,242,427
Ensembl chr11:73,218,281...73,242,427
G
PARD6B
par-6 family cell polarity regulator beta
increases expression
EXP
methylmercury II results in increased expression of PARD6B mRNA
CTD
PMID:26314263
NCBI chr20:50,731,580...50,753,741
Ensembl chr20:50,731,580...50,756,795
G
PDCL3
phosducin like 3
multiple interactions
ISO
[Benzene co-treated with methylmercury II co-treated with Trichloroethylene] results in increased expression of PDCL3 mRNA
CTD
PMID:17905399
NCBI chr 2:100,562,993...100,576,739
Ensembl chr 2:100,562,993...100,576,739
G
PIK3CA
phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha
increases expression
EXP
methylmercury II results in increased expression of PIK3CA mRNA
CTD
PMID:26314263
NCBI chr 3:179,148,126...179,240,093
Ensembl chr 3:179,148,114...179,240,093
G
PIK3CB
phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta
increases expression
EXP
methylmercury II results in increased expression of PIK3CB mRNA
CTD
PMID:26314263
NCBI chr 3:138,652,698...138,834,928
Ensembl chr 3:138,652,698...138,834,928
G
PIK3CG
phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma
increases expression
EXP
methylmercury II results in increased expression of PIK3CG mRNA
CTD
PMID:26314263
NCBI chr 7:106,865,282...106,908,980
Ensembl chr 7:106,865,278...106,908,980
G
PLCG1
phospholipase C gamma 1
decreases expression
EXP
methylmercury II results in decreased expression of PLCG1 mRNA
CTD
PMID:26314263
NCBI chr20:41,137,543...41,177,626
Ensembl chr20:41,136,960...41,196,801
G
PLCG2
phospholipase C gamma 2
decreases expression
EXP
methylmercury II results in decreased expression of PLCG2 mRNA
CTD
PMID:26314263
NCBI chr16:81,779,291...81,962,685
Ensembl chr16:81,779,279...81,962,685
G
PLD1
phospholipase D1
multiple interactions
ISO
[Benzene co-treated with methylmercury II co-treated with Trichloroethylene] results in increased expression of PLD1 mRNA
CTD
PMID:17905399
NCBI chr 3:171,600,404...171,810,483
Ensembl chr 3:171,600,404...171,810,950
G
PLPP1
phospholipid phosphatase 1
decreases expression
EXP
methylmercury II results in decreased expression of PPAP2A mRNA
CTD
PMID:26314263
NCBI chr 5:55,424,854...55,534,964
Ensembl chr 5:55,424,854...55,534,969
G
PLS3
plastin 3
multiple interactions
ISO
[Benzene co-treated with methylmercury II co-treated with Trichloroethylene] results in increased expression of PLS3 mRNA
CTD
PMID:17905399
NCBI chr X:115,561,174...115,650,861
Ensembl chr X:115,561,174...115,650,861
G
PRLR
prolactin receptor
multiple interactions
ISO
[Benzene co-treated with methylmercury II co-treated with Trichloroethylene] results in increased expression of PRLR mRNA
CTD
PMID:17905399
NCBI chr 5:35,048,756...35,230,487
Ensembl chr 5:35,048,756...35,230,487
G
PROC
protein C, inactivator of coagulation factors Va and VIIIa
multiple interactions
ISO
[Benzene co-treated with methylmercury II co-treated with Trichloroethylene] results in decreased expression of PROC mRNA
CTD
PMID:17905399
NCBI chr 2:127,418,427...127,429,242
Ensembl chr 2:127,418,427...127,429,242
G
PTEN
phosphatase and tensin homolog
multiple interactions increases expression
ISO EXP
[Benzene co-treated with methylmercury II co-treated with Trichloroethylene] results in increased expression of PTEN mRNA methylmercury II results in increased expression of PTEN mRNA
CTD
PMID:17905399 PMID:26314263
NCBI chr10:87,863,625...87,971,930
Ensembl chr10:87,862,638...87,971,930
G
PTH1R
parathyroid hormone 1 receptor
multiple interactions
ISO
[Benzene co-treated with methylmercury II co-treated with Trichloroethylene] results in decreased expression of PTH1R mRNA
CTD
PMID:17905399
NCBI chr 3:46,877,721...46,903,799
Ensembl chr 3:46,877,721...46,903,799
G
PTMS
parathymosin
multiple interactions
ISO
[Benzene co-treated with methylmercury II co-treated with Trichloroethylene] results in decreased expression of PTMS mRNA
CTD
PMID:17905399
NCBI chr12:6,766,363...6,770,952
Ensembl chr12:6,765,516...6,770,952
G
PTPN11
protein tyrosine phosphatase non-receptor type 11
increases expression
EXP
methylmercury II results in increased expression of PTPN11 mRNA
CTD
PMID:26314263
NCBI chr12:112,418,947...112,509,918
Ensembl chr12:112,418,351...112,509,918
G
PTPRF
protein tyrosine phosphatase receptor type F
multiple interactions
ISO
[Benzene co-treated with methylmercury II co-treated with Trichloroethylene] results in decreased expression of PTPRF mRNA
CTD
PMID:17905399
NCBI chr 1:43,522,051...43,623,666
Ensembl chr 1:43,525,187...43,623,666
G
RAB11B
RAB11B, member RAS oncogene family
increases expression
ISO
methylmercury II results in increased expression of RAB11B mRNA
CTD
PMID:17905399
NCBI chr19:8,390,360...8,404,434
Ensembl chr19:8,389,981...8,404,434
G
RAB9A
RAB9A, member RAS oncogene family
multiple interactions
ISO
[Benzene co-treated with methylmercury II co-treated with Trichloroethylene] results in increased expression of RAB9 mRNA
CTD
PMID:17905399
NCBI chr X:13,689,128...13,710,504
Ensembl chr X:13,689,128...13,710,504
G
RASSF5
Ras association domain family member 5
increases expression
EXP
methylmercury II results in increased expression of RASSF5 mRNA
CTD
PMID:26314263
NCBI chr 1:206,507,531...206,589,448
Ensembl chr 1:206,507,531...206,589,448
G
RGS3
regulator of G protein signaling 3
increases expression
ISO
methylmercury II results in increased expression of RGS3 mRNA
CTD
PMID:17905399
NCBI chr 9:113,444,730...113,597,738
Ensembl chr 9:113,444,731...113,597,743
G
RHOB
ras homolog family member B
multiple interactions
ISO
[Benzene co-treated with methylmercury II co-treated with Trichloroethylene] results in decreased expression of RHOB mRNA
CTD
PMID:17905399
NCBI chr 2:20,447,074...20,449,440
Ensembl chr 2:20,447,074...20,449,440
G
ROCK1
Rho associated coiled-coil containing protein kinase 1
increases expression
EXP
methylmercury II results in increased expression of ROCK1 mRNA
CTD
PMID:26314263
NCBI chr18:20,946,906...21,111,813
Ensembl chr18:20,944,612...21,111,813
G
ROCK2
Rho associated coiled-coil containing protein kinase 2
increases expression
EXP
methylmercury II results in increased expression of ROCK2 mRNA
CTD
PMID:26314263
NCBI chr 2:11,179,759...11,345,437
Ensembl chr 2:11,179,759...11,348,330
G
RTN4
reticulon 4
multiple interactions
ISO
[Benzene co-treated with methylmercury II co-treated with Trichloroethylene] results in increased expression of RTN4 mRNA
CTD
PMID:17905399
NCBI chr 2:54,972,189...55,137,831
Ensembl chr 2:54,972,187...55,112,621
G
SCNN1A
sodium channel epithelial 1 subunit alpha
increases expression
ISO
methylmercury II results in increased expression of SCNN1A mRNA
CTD
PMID:17905399
NCBI chr12:6,346,847...6,377,359
Ensembl chr12:6,346,843...6,377,730
G
SEMA4F
ssemaphorin 4F
decreases expression
EXP
methylmercury II results in decreased expression of SEMA4F mRNA
CTD
PMID:26314263
NCBI chr 2:74,654,247...74,709,713
Ensembl chr 2:74,654,228...74,683,853
G
SLC16A1
solute carrier family 16 member 1
multiple interactions
ISO
[Benzene co-treated with methylmercury II co-treated with Trichloroethylene] results in decreased expression of SLC16A1 mRNA
CTD
PMID:17905399
NCBI chr 1:112,911,847...112,956,196
Ensembl chr 1:112,911,847...112,957,593
G
SLC17A1
solute carrier family 17 member 1
increases expression
ISO
methylmercury II results in increased expression of SLC17A1 mRNA
CTD
PMID:17905399
NCBI chr 6:25,723,743...25,832,052
Ensembl chr 6:25,782,915...25,832,052
G
SLC17A3
solute carrier family 17 member 3
increases expression
ISO
methylmercury II results in increased expression of SLC17A3 mRNA
CTD
PMID:17905399
NCBI chr 6:25,844,856...25,874,243
Ensembl chr 6:25,833,066...25,882,286
G
SLC22A7
solute carrier family 22 member 7
decreases expression
ISO
methylmercury II results in decreased expression of SLC22A7 mRNA
CTD
PMID:17905399
NCBI chr 6:43,295,714...43,305,538
Ensembl chr 6:43,295,694...43,305,538
G
SOCS2
suppressor of cytokine signaling 2
increases expression
ISO
methylmercury II results in increased expression of SOCS2 mRNA
CTD
PMID:17905399
NCBI chr12:93,569,969...93,626,236
Ensembl chr12:93,569,814...93,583,487
G
SOS2
SOS Ras/Rho guanine nucleotide exchange factor 2
multiple interactions
ISO
[Benzene co-treated with methylmercury II co-treated with Trichloroethylene] results in increased expression of SOS2 mRNA
CTD
PMID:17905399
NCBI chr14:50,117,130...50,231,882
Ensembl chr14:50,117,130...50,231,578
G
SPARC
secreted protein acidic and cysteine rich
increases expression multiple interactions
ISO
methylmercury II results in increased expression of SPARC mRNA [Benzene co-treated with methylmercury II co-treated with Trichloroethylene] results in decreased expression of SPARC mRNA
CTD
PMID:17905399
NCBI chr 5:151,661,096...151,686,915
Ensembl chr 5:151,661,096...151,686,975
G
SPHK1
sphingosine kinase 1
decreases expression
EXP
methylmercury II results in decreased expression of SPHK1 mRNA
CTD
PMID:26314263
NCBI chr17:76,383,204...76,387,855
Ensembl chr17:76,376,584...76,387,860
G
SQSTM1
sequestosome 1
increases expression
ISO
methylmercury II results in increased expression of SQSTM1 mRNA
CTD
PMID:17905399
NCBI chr 5:179,806,393...179,838,078
Ensembl chr 5:179,806,398...179,838,078
G
STOM
stomatin
multiple interactions
ISO
[Benzene co-treated with methylmercury II co-treated with Trichloroethylene] results in decreased expression of STOM mRNA
CTD
PMID:17905399
NCBI chr 9:121,338,987...121,370,250
Ensembl chr 9:121,338,987...121,370,304
G
THY1
Thy-1 cell surface antigen
decreases expression
EXP
methylmercury II results in decreased expression of THY1 mRNA
CTD
PMID:26314263
NCBI chr11:119,415,476...119,424,985
Ensembl chr11:119,415,476...119,424,985
G
TNFRSF12A
TNF receptor superfamily member 12A
increases expression
ISO
methylmercury II results in increased expression of TNFRSF12A mRNA
CTD
PMID:17905399
NCBI chr16:3,020,368...3,022,383
Ensembl chr16:3,018,445...3,022,383
G
TNFRSF1A
TNF receptor superfamily member 1A
multiple interactions
ISO
[Benzene co-treated with methylmercury II co-treated with Trichloroethylene] results in decreased expression of TNFRSF1A mRNA
CTD
PMID:17905399
NCBI chr12:6,328,771...6,342,076
Ensembl chr12:6,328,757...6,342,114
G
TXNIP
thioredoxin interacting protein
multiple interactions
ISO
[Benzene co-treated with methylmercury II co-treated with Trichloroethylene] results in decreased expression of TXNIP mRNA
CTD
PMID:17905399
NCBI chr 1:145,992,435...145,996,579
Ensembl chr 1:145,992,435...145,996,579
G
TXNRD1
thioredoxin reductase 1
increases expression
ISO
methylmercury II results in increased expression of TXNRD1 mRNA
CTD
PMID:17905399
NCBI chr12:104,215,779...104,350,307
Ensembl chr12:104,215,779...104,350,307
G
VAV3
vav guanine nucleotide exchange factor 3
increases expression
EXP
methylmercury II results in increased expression of VAV3 mRNA
CTD
PMID:26314263
NCBI chr 1:107,571,161...107,965,180
Ensembl chr 1:107,571,161...107,965,180
G
YWHAQ
tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein theta
multiple interactions
ISO
[Benzene co-treated with methylmercury II co-treated with Trichloroethylene] results in increased expression of YWHAQ mRNA
CTD
PMID:17905399
NCBI chr 2:9,583,967...9,630,997
Ensembl chr 2:9,583,967...9,630,997
Term paths to the root one shortest all shortest one longest all longest one shortest and longest all